Display Settings:

Format

Send to:

Choose Destination
    Anticancer Res. 2008 Jan-Feb;28(1B):401-5.

    The ATM gene and ataxia telangiectasia.

    Source

    Department of Medical Genetics, Athens University School of Medicine, "Aghia Sofia" Childrens' Hospital, Thivon and Levadias, 115 27 Athens, Greece. ariamav@hol.gr

    Abstract

    Ataxia telangiectasia (AT) is a rare neurodegenerative, autosomal recessive disorder characterized by chromosome instability, radiosensitivity, immunodeficiency and a predisposition for cancer. Epidemiological studies have shown that AT heterozygotes have a predisposition for cancer, especially for breast cancer in women. The disease is caused by mutations in the ATM gene, leading to total loss of the ATM protein, which normally recognizes DNA damage, activates the DNA repair machinery and the cell cycle check points in order to minimize the risk of genetic damage. This review summarizes the clinical features of AT and the natural history of the disease and puts recent molecular advances into the context of the cellular and clinical phenotype.

    PMID:
    18383876
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk